Pharmacy Times Continuing Education™ Marks Record Growth for Directions in Pharmacy® Spring Conference Series

The last two conferences will take place in Nashville, Tennessee; and
New Brunswick, New Jersey

CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DIP2019?src=hash" target="_blank"gt;#DIP2019lt;/agt;–Pharmacy Times Continuing Education™ (PTCE), a leader in
continuing education for retail, health-system, managed care and
specialty pharmacists, has experienced record growth for the first two
2019 Directions in Pharmacy^® (DIP) conferences compared with
2018.

“We are really proud of the continuous growth and excitement that our
DIP conferences have generated,” said Jim Palatine, RPh, MBA,
president of PTCE. “The conferences offer pharmacists an
opportunity to gain insights from expert faculty and be exposed to
education that is extremely relevant to their practices.”

The 2019 DIP Spring Conference Series will be held in four total
locations. This year’s attendance for the Chicago conference increased
97% over 2018, while in Anaheim, California, attendance increased by
74%. So far, the conferences have educated a combined 288 pharmacists
and health care providers. The next DIP conference will take place on
Saturday, May 18, at the Nashville Airport Marriott, in Nashville,
Tennessee, and feature Lee Holland-Skipper, Pharm.D., MPH, research
fellow of the Pharmacy Quality Alliance (PQA) providing the keynote
address. The final conference in the series will take place on Saturday,
June 22, at the Hyatt Regency in New Brunswick, New Jersey, with guest
keynote speaker Laura Cranston, RPh, chief executive officer of the PQA.
Both speakers will provide accredited education on the opioid epidemic
and steps that pharmacists can take to improve patient care, as well as
examine the clinical and economic impact to patients and the health care
system.

The DIP Spring Conference Series is held in major cities across the
United States and offers pharmacists the opportunity to participate in
10 interactive sessions. The meetings cover the most recent and relevant
information on disease-state management, clinical data and treatment
guidelines as well as best practices for patient care for a wide array
of disease states, including opioid abuse-deterrent formulations,
migraine management, metabolic and cardiovascular disorders, new
influenza treatment recommendations, chronic idiopathic constipation and
depression. Accredited by the Accreditation Council for Pharmacy
Education (ACPE), each meeting provides attendees with the opportunity
to earn up to 9.5 continuing education credits, including law credit.

This conference series is supported by educational grants from Amgen;
Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Daiichi
Sankyo, Inc.; Genentech; Lilly; Novartis Pharmaceutical Corporation;
Novo Nordisk; Otsuka and Lundbeck; Portola Pharmaceuticals; Sanofi
Pasteur US; Sanofi US and Regeneron Pharmaceuticals; and Shire, now part
of Takeda.

For more information and to register for a conference, click here.

About Pharmacy Times Continuing Education™

Pharmacy Times Continuing Education™ (PTCE) is a
leader in continuing education for retail, health system, managed care
and specialty pharmacists. PTCE is accredited by the
Accreditation Council for Pharmacy Education as a provider of continuing
pharmacy education (CPE). PTCE’s print, online and live CPE
activities are designed to help improve the knowledge, competence and
skills of pharmacists so they are better prepared to provide the highest
quality of pharmacy care to the patients they serve and to the
physicians they assist as part of a multidisciplinary treatment and
management team. To learn more about the educational activities
sponsored by PTCE, visit https://www.pharmacytimes.org/.

Contacts

PTCE Media
Alexandra Ventura, 609-716-7777,
ext. 121
[email protected]

John Patricolo, 609-325-4630
[email protected]